Vertex Pharmaceuticals Incorporated (0QZU.L) LSE
441.71
-5.89(-1.32%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
441.71
-5.89(-1.32%)
Currency In USD
| Market Cap | 115.92B |
| Enterprise Value | 114.72B |
| P/E Ratio | 28.18 |
| PEG Ratio | 3.54 |
| Price/Sales Ratio | 9.26 |
| Price/Book Ratio | 5.97 |
| Enterprise/Revenue | 9.16 |
| Enterprise/EBITDA | 22.82 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.33 |
| Operating Margin | 0.35 |
| Return On Assets | 0.15 |
| Return On Equity | 0.23 |
| Revenue | 12.07B |
| Revenue/Share | 47.41 |
| Gross Profit | 10.27B |
| EBITDA | 4.97B |
| Net Income | 3.95B |
| Diluted EPS | 15.32 |
| Total Cash | 6.61B |
| Total Cash/Share | 26.04 |
| Total Debt | 3.88B |
| Total Debt/Equity | 0.21 |
| Current Ratio | 2.9 |
| Book Value Per Share | 73.52 |
| 52-Week Change | -10.1 |
| 52-Week High | 461.71 |
| 52-Week Low | 290.87 |
| Moving Average 50 Days | 424.38 |
| Moving Average 200 Days | 373.25 |
| Average Volume | 2,907 |
| Shares Outstanding | 257M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |